Using pilot study information to increase efficiency in clinical trials

DOI10.1016/J.JSPI.2006.07.010MaRDI QIDQ2455702zbMATH OpenOpenAlexFDO

Authors Samuel S. Wu, Mark C. K. Yang

Publication date 26 October 2007

Published in Journal of Statistical Planning and Inference (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.jspi.2006.07.010

zbMATH Keywords

\(t\)-testpowershrinkage testunivariate linear hypothesis

Mathematics Subject Classification ID

Bayesian inference (62F15) Testing in survival analysis and censored data (62N03) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• scientific article; zbMATH DE number 1222379
• Some aspects of the application of internal pilot studies
• Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework
• On the Use of the Upper Confidence Limit for the Variance from a Pilot Sample for Sample Size Determination
• A sample size adjustment procedure for clinical trials based on conditional power

Cites work

• Bayesian analysis of a three-component hierarchical design model
• Controlling test size while gaining the benefits of an internal pilot design
• scientific article; zbMATH DE number 3141625 (Why is no real title available?)
• scientific article; zbMATH DE number 48191 (Why is no real title available?)
• scientific article; zbMATH DE number 3551712 (Why is no real title available?)
• On the Power Function of the Analysis of Variance Test
• On the Power Functions of the E²-Test and the T²-Test
• On the Use of the Upper Confidence Limit for the Variance from a Pilot Sample for Sample Size Determination
• Tests with optimal average power in multivariate analysis

Cited in

(4)

• Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model
• scientific article; zbMATH DE number 1222379 (Why is no real title available?)
• PILOT TRIAL FOR THE ASSESSMENT OF RELATIVE BIOAVAILABILITY IN GENERIC DRUG PRODUCT DEVELOPMENT: STATISTICAL POWER
• Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework

This page was built for publication: Using pilot study information to increase efficiency in clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2455702)